These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 14551176)

  • 1. Dose equivalency evaluation of major corticosteroids: pharmacokinetics and cell trafficking and cortisol dynamics.
    Mager DE; Lin SX; Blum RA; Lates CD; Jusko WJ
    J Clin Pharmacol; 2003 Nov; 43(11):1216-27. PubMed ID: 14551176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the administration time effect on the cumulative cortisol suppression and cumulative lymphocytes suppression for once-daily inhaled corticosteroids: a population modeling/simulation approach.
    Wu K; Goyal N; Stark JG; Hochhaus G
    J Clin Pharmacol; 2008 Sep; 48(9):1069-80. PubMed ID: 18728243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical PK/PD modelling as a tool in drug development of corticosteroids.
    Derendorf H; Möllmann H; Hochhaus G; Meibohm B; Barth J
    Int J Clin Pharmacol Ther; 1997 Oct; 35(10):481-8. PubMed ID: 9352400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylprednisolone pharmacokinetics and pharmacodynamics in chronic renal failure.
    Jusko WJ; Milad MA; Ludwig EA; Lew KH; Kohli RK
    Clin Nephrol; 1995 Jan; 43 Suppl 1():S16-9. PubMed ID: 7781199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic and pharmacodynamic assessments of the dipeptidyl peptidase-4 inhibitor PHX1149: double-blind, placebo-controlled, single- and multiple-dose studies in healthy subjects.
    O'Farrell AM; van Vliet A; Abou Farha K; Cherrington JM; Campbell DA; Li X; Hanway D; Li J; Guler HP
    Clin Ther; 2007 Aug; 29(8):1692-705. PubMed ID: 17919550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population pharmacokinetic/pharmacodynamic modeling of systemic corticosteroid inhibition of whole blood lymphocytes: modeling interoccasion pharmacodynamic variability.
    Hong Y; Mager DE; Blum RA; Jusko WJ
    Pharm Res; 2007 Jun; 24(6):1088-97. PubMed ID: 17385022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects.
    Ramael S; De Smedt F; Toublanc N; Otoul C; Boulanger P; Riethuisen JM; Stockis A
    Clin Ther; 2006 May; 28(5):734-44. PubMed ID: 16861095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of GH reserve in patients with adrenal incidentalomas and biochemical evidence of subclinical autonomous glucocorticoid hypersecretion.
    Tzanela M; Zianni D; Stylianidou Ch; Karavitaki N; Tsagarakis S; Thalassinos NC
    Clin Endocrinol (Oxf); 2005 May; 62(5):597-602. PubMed ID: 15853831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pharmacokinetic/pharmacodynamic approach to predict the cumulative cortisol suppression of inhaled corticosteroids.
    Meibohm B; Hochhaus G; Möllmann H; Barth J; Wagner M; Krieg M; Stöckmann R; Derendorf H
    J Pharmacokinet Biopharm; 1999 Apr; 27(2):127-47. PubMed ID: 10567952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioequivalence of two commercial preparations of trimethoprim/sulfamethoxazole: a randomized, single-dose, single-blind, crossover trial.
    Alonso Campero R; Bernardo Escudero R; Del Cisne Valle Alvarez D; González de la Parra M; Namur Montalvo S; Burke Fraga V; Silva Hernandez R; De Lago Acosta A
    Clin Ther; 2007 Feb; 29(2):326-33. PubMed ID: 17472824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and bioequivalence study of two tablet formulations of lovastatin in healthy volunteers.
    Mignini F; Tomassoni D; Streccioni V; Traini E; Amenta F
    Clin Exp Hypertens; 2008 Feb; 30(2):95-108. PubMed ID: 18293165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive effects of intravenous hydrocortisone in subjects with PTSD and healthy control subjects.
    Grossman R; Yehuda R; Golier J; McEwen B; Harvey P; Maria NS
    Ann N Y Acad Sci; 2006 Jul; 1071():410-21. PubMed ID: 16891588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and bioequivalence evaluation of 2 levosulpiride preparations after a single oral dose in healthy male Korean volunteers.
    Cho HY; Moon JD; Lee YB
    Int J Clin Pharmacol Ther; 2004 Mar; 42(3):174-80. PubMed ID: 15049438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sample size calculation for the Power Model for dose proportionality studies.
    Sethuraman VS; Leonov S; Squassante L; Mitchell TR; Hale MD
    Pharm Stat; 2007; 6(1):35-41. PubMed ID: 17323313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal corticosteroids and adrenal suppression.
    Bruni FM; De Luca G; Venturoli V; Boner AL
    Neuroimmunomodulation; 2009; 16(5):353-62. PubMed ID: 19571596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling interactions between adrenal suppression and T-helper lymphocyte trafficking during multiple dosing of methylprednisolone.
    Chow FS; Sharma A; Jusko WJ
    J Pharmacokinet Biopharm; 1999 Dec; 27(6):559-75. PubMed ID: 11153446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cortisol levels and corticosteroid administration fail to predict mortality in critical illness: the confounding effects of organ dysfunction and sex.
    Rady MY; Johnson DJ; Patel B; Larson J; Helmers R
    Arch Surg; 2005 Jul; 140(7):661-8; discussion 669. PubMed ID: 16027331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacodynamic model for joint exogenous and endogenous corticosteroid suppression of lymphocyte trafficking.
    Milad MA; Ludwig EA; Anné S; Middleton E; Jusko WJ
    J Pharmacokinet Biopharm; 1994 Dec; 22(6):469-80. PubMed ID: 7473077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-response relationship of an oral insulin spray in six patients with type 1 diabetes: a single-center, randomized, single-blind, 5-way crossover study.
    Cernea S; Kidron M; Wohlgelernter J; Raz I
    Clin Ther; 2005 Oct; 27(10):1562-70. PubMed ID: 16330292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.